SciELO - Scientific Electronic Library Online

 
vol.17 issue2Autoinflammatory DiseasesAsociation between systemic lupus erythematosus and multiple sclerosis: lupoid sclerosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

FERNANDEZ AVILA, Daniel G et al. Pharmacological treatment of postmenopausal osteoporosis. Rev.Colomb.Reumatol. [online]. 2010, vol.17, n.2, pp.96-110. ISSN 0121-8123.

Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

Keywords : osteoporosis; fracture; menopause; bone mineral density.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License